Dr. Qian Peng is the group leader of photodynamic therapy and photodetection in the Department of Pathology, Oslo University Hospital, Oslo, Norway. His group has recently been developing a novel version of extracorporeal photopheresis technology using 5-aminolevulinic acid, a precursor to the potent photosensitiser protoporphyrin IX in the heme biosynthesis pathway.
CRDWC 2025
Keynote Presentation